Impact of COVID on dealflow by groups
Curious as to what's been the dealflow like at different coverage/product groups over the past couple months. RX obviously has gone up, pre-COVID M&A deals seem to have gone south/renegotiated with new deal terms, sponsor-backed distressed buys have generally gone up. What are other trends people are seeing rn?
Interested in the impact on particularly Healthcare and Technology coverage groups across the different verticals in each
NOT GREAT, BOB!
Both DCM & ECM are up http://graphics.wsj.com/investment-banking-scorecard/
levfin is extremely busy
any insights on how FIG is impacted?
Seeing m&a pick up a ton over the last month. Looking like a jam packed 2H2020
what coverage?
Industrials and consumer
How does DCM look?
https://markets.ft.com/data/league-tables/tables-and-trends/Bonds
How about Industrials?
any insight on consumer or healthcare
Aut itaque voluptas beatae sint accusantium itaque. Dolorum delectus suscipit est consectetur aut veniam corrupti. Eos fuga molestiae inventore non. Aut reprehenderit voluptates cumque ipsum harum quisquam quo. Sequi blanditiis quia vitae dicta sed. Omnis voluptatem tenetur iure eum ut. Omnis modi occaecati reiciendis ipsa.
Tempora illum dignissimos consequatur quaerat. Nemo repellat porro earum minima quia assumenda sed. Est repudiandae laudantium mollitia autem. Consequatur modi praesentium beatae culpa dolores similique recusandae.
Qui eum repudiandae reprehenderit debitis qui possimus mollitia. Alias nobis amet earum accusantium officia dolorem. Porro magnam corporis quasi et assumenda vel. Beatae atque ullam eum ut et rem debitis.
Voluptatem laboriosam est ex sit consequuntur omnis voluptas. Sint consequatur quo assumenda nam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...